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COVID-19 transmission rates among vaccinated persons
attending large gatherings have not been reported widely. This
research was intended to track the potential incidence of
COVID-19 among physicians and their families who attended a
large in-person gathering in Atlanta in August 2021. Among the
520 participants of the meeting, no COVID-19 illness was
reported up to six weeks after attending the convention. This
report confirms the efficacy of COVID-19 mRNA vaccines
against protection from COVID-19 illness among participants of
large scale indoor gatherings. Our findings support the notion
that large-scale events can be successfully conducted among
fully vaccinated persons who follow public health guidelines.
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________________________________________________________________________________________
Background | Health care providers are at varying
risks of getting COVID-19 infections.1 During the
pandemic, the ability to meet people and attend
medical conferences in person has been curtailed.2,3
COVID-19 transmission rates among vaccinated
persons attending large gatherings have not been
reported widely. We aim to report the successful
hosting of an in-person meeting in Atlanta, Georgia,
U.S.A, of nearly 500 people, amidst the lifting of the
travel and public gathering restrictions. Physicians and
their families from different parts of North America
attended the conference. CDC guidelines and public
health measures such as wearing masks, social
distancing, and vaccine mandates by every attendee
was highly encouraged. About six weeks after the
convention, we conducted an assessment to investigate
if any of the attendees developed COVID-19 illness
after returning from the convention.
To determine the potential incidence of COVID-19
infection among physicians and their families who
attended a large in-person gathering in August 2021.

Methods | Our event was held in Atlanta, Georgia,
U.S.A on August 13 and 14, 2021 at a corporate hotel.
We distributed virtual surveys that was created using
Google Forms. Emails of participants were collected
during the convention as well as by distributing the
survey link on social media groups that contained a
majority of the attendees. We also contacted the
attendees by telephone to gather pending information
about their COVID-19 status, after attending the
meeting. We encouraged all attendees of the
convention to self-report the incidence of COVID-19
illness.
Informed consent was implied upon completion of the
survey. The time of data collection was extended to six
weeks after the conclusion of the meeting on August
14, 2021. The survey was sent on September 4th,
2021, which was twenty days after the convention. 143
attendees voluntarily completed this survey within six
weeks. The survey was completely anonymous. We
collected basic information such as age, gender, and
place of residence. Next, information about the
vaccination status of the attendees was collected
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including the number of vaccine doses, type of
vaccine, and date of each dose. Questions
underscoring behavioral and convention factors that
would have contributed to the infection rates including
the amount of time spent at the convention and
adherence to public health measures were included
(i.e. use of masks, gloves, social distancing). Current
COVID-19 infection status, symptoms, and severity
were also asked in the questionnaire. Finally,
information about prior infection of COVID-19 and
use of preventative medications such as
Hydroxychloroquine or Ivermectin was asked to
consider if these factors impact attendees’ current
COVID-19 status.
Results | Most attendees were physicians, other
employees in the healthcare industry or
family members of healthcare professionals. Among
the 143 participants of the meeting, no COVID-19
illness was reported up to a month after attending the
convention. None of the attendees who responded had
any symptoms or tested positive for COVID-19
infection six weeks after leaving the convention. None
reported being diagnosed with COVID-19 for at least
30 days before attending the convention. When asked
about any prophylactic measures such as
Hydroxychloroquine or Ivermectin, 99% responded
negatively – not taking.
As a sub-group analysis, we obtained demographic
data from the 143 attendees. Among the survey
respondents, 43% were over the age of 60 years, 10%
were over the age of 70 years, 29% were between 46
and 60 years, 14% each between 31-45 years and 1230 years. 53% were women. Of the attendees who
responded to the survey, 99% had received both doses
of the vaccine before attending the convention; 59%
received Pfizer and 39% got the Moderna vaccine. The
remaining got either Astrazeneca or Johnson &
Johnson vaccine. Most of them received their vaccines
in January and February (first dose 44% and second
dose 59%). Public health measures including the use
of indoor masks, social distancing, and personal
hygiene were followed by 76%. Attendees were from
different states of the USA. 25% percent were from
Georgia.
Discussion | This study focused on the incidence of
symptomatic COVID-19 infections in a group of 143
individuals attending an in-person gathering in Atlanta
amidst the COVID-19 pandemic. All attendees took
precautionary measures, maintaining social distancing
and utilizing personal protective equipment (PPE)
when applicable, during the convention to prevent
transmission of the virus. Results demonstrated that
none of the attendees and their respective families
developed symptomatic COVID-19 symptoms or
tested positive for the virus up to six weeks after the

convention. All the attendees were fully vaccinated
which demonstrates the effectiveness of the vaccine in
preventing breakthrough infections.
Recently, breakthrough infections are rising amongst
the fully vaccinated despite the high level of vaccine
efficacy.4 A total of 10, 262 COVID-19 breakthrough
infections have been reported from the 46 U.S states
and territories as of April 30, 2021.5 Among these
cases, 63% occurred in females, with a median age of
58 years. Results from our study suggest the efficacy
of the vaccine in preventing breakthrough infections.
Our attendees did not have symptomatic COVID-19
infection which could be attributed to maintaining
social distance protocols and wearing appropriate
PPE. It is possible that the attendees did develop
COVID-19 infection but did not display any overt
symptoms. The virus may have been transmitted to
their family members, who most likely were fully
vaccinated, and may have not developed any
symptoms. Furthermore, attendees that came from
different countries (i.e. Canada) were required to have
a COVID-19 negative test before attending the
convention and soon after arrival to their home
country. With the appropriate social distancing
measures, vaccination requirements, and strict travel
protocols, the transmission of COVID-19 may have
been limited.
On the contrary, one study suggests otherwise. A study
by Brown and colleagues analyzed COVID-19
infections in July 2021 following multiple large public
gatherings in Massachusetts, U.S.A.7 They identified
469 COVID-19 cases among the attendees out of
which 74% occurred in fully vaccinated individuals
with symptomatic infections in 79% of the attendees.
Further analysis revealed that the Delta variant was
seen in 90% of them. Among the five COVID-19
patients who were hospitalized, four were fully
vaccinated. No deaths were reported.7 This study
contradicts our results regarding breakthrough
infections. At this point, there is no clear explanation
for the difference in results. Robinson et al reported
the successful holding of an international golfing event
but this was mainly possible through rigorous daily
testing of attendees.8
Our study has several strengths including
documentation of the successful hosting of a large
indoor gathering in a safe setting with no outbreak
among the attendees. This was possible due to
strict adherence to public health guidelines and high
vaccination rates among attendees. Our report
provides optimism that such meetings can be held
safely in the future among fully vaccinated individuals
with the implementation of appropriate public health
directives. Limitations of our study include
documentation of COVID-19 illness based on selfreporting instead of formal diagnostic tests, potential
under-diagnosis or under-reporting of asymptomatic
infections, availability of demographic parameters,
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type or timing of vaccination only in a subgroup of
subjects, and lack of data about the underlying health
conditions of participants. However, thanks to our
extensive post-meeting surveillance, we can be
reassured that none of the attendees had symptomatic
COVID-19 infection even though a significant
proportion of attendees were aged more than 50 years
with potential comorbid illnesses. It is also possible
that all our attendees were highly aware of public
health and safety as most of them either work or were
family members of healthcare professionals.
Recommendations | This report confirms the efficacy
of COVID-19 mRNA vaccines against protection
from COVID-19 illness among participants of largescale indoor gatherings. Our findings support the
the notion that large-scale events can be successfully
conducted among fully vaccinated persons who follow
public health guidelines.
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